R Gomez-Flores1, I Gutierrez-Leal1, D Caballero-Hernández2, A Orozco-Flores1, P Tamez-Guerra1, R Tamez-Guerra1, C Rodríguez-Padilla1. 1. Laboratorio de Inmunología y Virología, Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, Apartado postal 46 F, San Nicolás de los Garza, 66451, NL, México. 2. Laboratorio de Inmunología y Virología, Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, Apartado postal 46 F, San Nicolás de los Garza, 66451, NL, México. diana.caballerohr@uanl.edu.mx.
Abstract
OBJECTIVE: Lymphocytes express tyrosine hydroxylase (TH), the rate-limiting enzyme for the synthesis of dopamine, norepinephrine and epinephrine. This suggests a broader role for cathecholamines in lymphocyte function, as well as the potential secretion of catecholamines by tumors of lymphoid origin. Our aim was to evaluate the expression of Th by murine lymphoma cells in an in vivo mouse model. For this, L5178Y-R lymphoma cells were implanted in nerve-intact and sympathectomized male BALB/c mice. Relative Th gene expression in tumor and brain was determined by quantitative PCR. Body composition, tumor volume, and plasma TH1/TH2/TH17 cytokines were also evaluated as markers of tumor-host condition and anti-tumor immune response in absence of adrenergic innervation. RESULTS: We found a significant (p = 0.045) 3.3-fold decrease of Th gene expression in tumor and a non-significant (p = 0.60) 6.9-fold increase in brain after sympathectomy. Sympathectomized mice also showed a significant increase in tumor mass at days 18 (p = 0.032) and 28 (p = 0.022) and increased interscapular fat (p = 0.04). TH1/TH2 and TH17 cytokines levels in plasma from sympathectomized tumor-bearing mice were not different from control mice. CONCLUSION: The L5178Y-R lymphoma does not express Th during in vivo progression.
OBJECTIVE: Lymphocytes express tyrosine hydroxylase (TH), the rate-limiting enzyme for the synthesis of dopamine, norepinephrine and epinephrine. This suggests a broader role for cathecholamines in lymphocyte function, as well as the potential secretion of catecholamines by tumors of lymphoid origin. Our aim was to evaluate the expression of Th by murine lymphoma cells in an in vivo mouse model. For this, L5178Y-R lymphoma cells were implanted in nerve-intact and sympathectomized male BALB/c mice. Relative Th gene expression in tumor and brain was determined by quantitative PCR. Body composition, tumor volume, and plasma TH1/TH2/TH17 cytokines were also evaluated as markers of tumor-host condition and anti-tumor immune response in absence of adrenergic innervation. RESULTS: We found a significant (p = 0.045) 3.3-fold decrease of Th gene expression in tumor and a non-significant (p = 0.60) 6.9-fold increase in brain after sympathectomy. Sympathectomized mice also showed a significant increase in tumor mass at days 18 (p = 0.032) and 28 (p = 0.022) and increased interscapular fat (p = 0.04). TH1/TH2 and TH17 cytokines levels in plasma from sympathectomized tumor-bearing mice were not different from control mice. CONCLUSION: The L5178Y-R lymphoma does not express Th during in vivo progression.
Authors: D Caballero-Hernandez; D Najera-Valderrabano; A Valadez-Lira; M Franco-Molina; R Gomez-Flores; P Tamez-Guerra; R Tamez-Guerra; C Rodríguez-Padilla Journal: Exp Oncol Date: 2017-12
Authors: Michele Petruzzelli; Martina Schweiger; Renate Schreiber; Ramon Campos-Olivas; Maria Tsoli; John Allen; Michael Swarbrick; Stefan Rose-John; Mercedes Rincon; Graham Robertson; Rudolf Zechner; Erwin F Wagner Journal: Cell Metab Date: 2014-07-17 Impact factor: 27.287
Authors: Marcela Laukova; Peter Vargovic; Miroslav Vlcek; Katarina Lejavova; Sona Hudecova; Olga Krizanova; Richard Kvetnansky Journal: Immunobiology Date: 2012-08-30 Impact factor: 3.144
Authors: Marco Cosentino; Anna Maria Fietta; Marco Ferrari; Emanuela Rasini; Raffaella Bombelli; Elena Carcano; Federica Saporiti; Federica Meloni; Franca Marino; Sergio Lecchini Journal: Blood Date: 2006-09-19 Impact factor: 22.113
Authors: Phillip Jobling; Jay Pundavela; Sonia M R Oliveira; Séverine Roselli; Marjorie M Walker; Hubert Hondermarck Journal: Cancer Res Date: 2015-03-20 Impact factor: 12.701
Authors: P Workman; E O Aboagye; F Balkwill; A Balmain; G Bruder; D J Chaplin; J A Double; J Everitt; D A H Farningham; M J Glennie; L R Kelland; V Robinson; I J Stratford; G M Tozer; S Watson; S R Wedge; S A Eccles Journal: Br J Cancer Date: 2010-05-25 Impact factor: 7.640